Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
Clinical trial NCT00045032 · COMPLETED
Trial details
- NCT number
- NCT00045032
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2005-03-01
- Enrollment
- 5099
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.